Does IMIQUIMOD Cause Basal cell carcinoma? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Basal cell carcinoma have been filed in association with IMIQUIMOD (Imiquimod). This represents 0.7% of all adverse event reports for IMIQUIMOD.
12
Reports of Basal cell carcinoma with IMIQUIMOD
0.7%
of all IMIQUIMOD reports
1
Deaths
1
Hospitalizations
How Dangerous Is Basal cell carcinoma From IMIQUIMOD?
Of the 12 reports, 1 (8.3%) resulted in death, 1 (8.3%) required hospitalization.
Is Basal cell carcinoma Listed in the Official Label?
Yes, Basal cell carcinoma is listed as a known adverse reaction in the official FDA drug label for IMIQUIMOD.
What Other Side Effects Does IMIQUIMOD Cause?
Off label use (264)
Product use in unapproved indication (179)
Erythema (171)
Drug ineffective (123)
Fatigue (118)
Influenza like illness (101)
Pain (98)
Application site erythema (95)
Nausea (90)
Headache (79)
What Other Drugs Cause Basal cell carcinoma?
ADALIMUMAB (1,547)
INFLIXIMAB (1,340)
METHOTREXATE (1,268)
RITUXIMAB (1,085)
ETANERCEPT (998)
ABATACEPT (852)
TOCILIZUMAB (761)
LENALIDOMIDE (685)
HYDROXYCHLOROQUINE (662)
LEFLUNOMIDE (657)
Which IMIQUIMOD Alternatives Have Lower Basal cell carcinoma Risk?
IMIQUIMOD vs IMITREX
IMIQUIMOD vs IMMUNE GLOBULIN NOS
IMIQUIMOD vs IMPLANON
IMIQUIMOD vs INAVOLISIB
IMIQUIMOD vs INCIVEK